Delivery Order SPE2DB20D3103-SPE2DB25FN6V0
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,332.18 firm fixed-price delivery order is for the supply of 4566640905 - Phenobarbital 130 mg/ml vial/ml. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.43, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,296.66 firm fixed-price delivery order is for the procurement of 4567673577 ! PHENOBARBITAL 130 MG/ML VIALML, with a completion date of March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567265456 - PHENOBARBITAL 130 MG/ML VIALML. The contract has a ceiling value of $3,147.26 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of February 14, 2025. This award does not have a set-aside designation, indicating it was open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under Contract SPE2DX15D3026/SPE2DX24FUXDA with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,241.12, is for the supply of PHENOBARBITAL 65 MG/ML VIAL. This delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $13,857.65 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 130 mg/mL vials of the pharmaceutical Phenobarbital. This delivery order was issued under an Indefinite Delivery Contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
This federal contract award, valued at $2,173.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of PHENOBARBITAL 130 MG/ML VIALML, a pharmaceutical product, through December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $7,906.95 and a period of performance ending on July 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these essential pharmaceutical products to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,065.20 firm-fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL solution, a critical medication, to support federal healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...